269
Views
10
CrossRef citations to date
0
Altmetric
Original Articles: Gynaecology

Nicotinamide N-methyltransferase overexpression may be associated with poor prognosis in ovarian cancer

, , , , , & show all

References

  • Beesley VL, Green AC, Wyld DK, O’Rourke P, Wockner LF, deFazio A, et al. 2014. Quality of life and treatment response among women with platinum-resistant versus platinum-sensitive ovarian cancer treated for progression: a prospective analysis. Gynecologic Oncology 132:130–136.
  • Campagna R, Cecati M, Pozzi V, Fumarola S, Pompei V, Milanese G, et al. 2018. Involvement of transforming growth factor beta 1 in the transcriptional regulation of nicotinamide N-methyltransferase in clear cell renal cell carcinoma. Cellular and Molecular Biology 64:51–55.
  • Chen C, Wang X, Huang X, Yong H, Shen J, Tang Q, et al. 2016. Clinical practice. Screening for ovarian cancer. American Journal of Cancer Research 6:649–663.
  • Clarke-Pearson DL. 2009. Clinical Practice. Screening for Ovarian Cancer. N Engl J Med 361:170–177.
  • Eckert MA, Coscia F, Chryplewicz A, Chang JW, Hernandez KM, Pan S, et al. 2019. Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts. Nature 569:723–728.
  • Kanska J, Aspuria P-JP, Taylor-Harding B, Spurka L, Funari V, Orsulic S, et al. 2017. Glucose deprivation elicits phenotypic plasticity via ZEB1-mediated expression of NNMT. Oncotarget 8:26200–26220.
  • Kim J, Hong SJ, Lim EK, Yu YS, Kim SW, Roh JH, Do IG, et al. 2009. Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis. Journal of Experimental and Clinical Cancer Research 28:20.
  • Kurman RJ, Carcangiu ML, Herrington CS, Young, RH. (2014) WHO Classification of Tumours of Female Reproductive Organs. In WHO Classification of Tumours. 4. Aufl. Lyon: WHO Press.
  • Lamouille S, Xu J, Derynck R. 2014. Molecular mechanisms of epithelial-mesenchymal transition. Nature Reviews Molecular Cell Biology 15:178–196.
  • Liang L, Zeng M, Pan H, Liu H, He Y. 2018. Nicotinamide N-methyltransferase promotes epithelial-mesenchymal transition in gastric cancer cells by activating transforming growth factor-β1 expression. Oncology Letters 15:4592–4598.
  • Palanichamy K, Kanji S, Gordon N, Thirumoorthy K, Jacob JR, Litzenberg KT, et al. 2017. NNMT silencing activates tumor suppressor PP2A, inactivates oncogenic stks, and inhibits tumor forming ability. Clinical Cancer Research 23:2325–2334.
  • Pozzi V, Sartini D, Rocchetti R, Santarelli A, Rubini C, Morganti S, et al. 2015. Identification and characterization of cancer stem cells from head and neck squamous cell carcinoma cell lines. Cellular Physiology and Biochemistry 36:784–798.
  • Prat J, FIGO Committee on Gynecologic Oncology. 2014. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. International Journal of Gynecology and Obstetrics 124:1–5.
  • Siegel RL, Miller KD, Jemal A. 2017. Cancer statistics, 2017. CA: A Cancer Journal for Clinicians 67:7–30.
  • Tothill RW, Tinker AV, George J, Brown R, Fox SB, Lade S, et al. 2008. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clinical Cancer Research 14:5198–5208.
  • Ulanovskaya OA, Zuhl AM, Cravatt BF. 2013. NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink. Nature Chemical Biology 9:300–306.
  • Whatcott CJ, Diep CH, Jiang P, Watanabe A, LoBello J, Sima C, et al. 2015. Desmoplasia in primary tumors and metastatic lesions of pancreatic cancer. Clinical Cancer Research 21:3561–3568.
  • Xie X, Liu H, Wang Y, Zhou Y, Yu H, Li H, et al. 2016. Nicotinamide N-methyltransferase enhances resistance to 5-fluorouracil in colorectal cancer cells through inhibition of the ASK1-p38 MAPK pathway. Oncotarget 7:45837–45848.
  • Xu Y, Liu P, Zheng DH, Wu N, Zhu L, Xing C, et al. 2016. Expression profile and prognostic value of NNMT in patients with pancreatic cancer. Oncotarget 7:19975–19981.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.